Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

iKure Techsoft raises $1.8M in Pre-Series A funding from Philips Foundation, World Diabetes Foundation, and Bayer Foundation to scale technology-enabled primary healthcare across India.

PRIVATESep 14, 2026•about 3 hours ago

Amount Raised

$1.8 Million

Round Type

Series A

IndiaBiotechnologyHealth CareMedical

Investors

Prourgn LlcWe Share ForwardBayer FoundationWorld Diabetes FoundationPhilips Foundation

Description

iKure Techsoft Private Limited has secured $1.8 million in Pre-Series A funding from four global healthcare and philanthropic investors including Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Prourgn LLC of Japan. The funding will support expansion of iKure's technology-enabled primary healthcare services across underserved regions of India, where it currently operates across 11 states and reaches over 36 million people. The capital will be directed towards expanding healthcare hubs, clinics, pharmacies, and diagnostic capacity, as well as enhancing WHIMS, the company's proprietary digital health platform, with AI-enabled clinical decision-support capabilities. iKure's model focuses on continuity of care for chronic conditions through its network of community health activists and women-led self-help groups.

Company Information

Company

iKure Techsoft Private Limited

Location

India

About

iKure Techsoft Private Limited is a technology-enabled primary healthcare company operating across 11 states in India, reaching over 36 million people through a network of healthcare hubs, clinics, pharmacies, diagnostics, and telemedicine services. The company uses its proprietary digital health platform WHIMS and works with over 400 Community Health Activists and 10,000 women-led Self-Help Groups to deliver care in underserved regions. iKure focuses on continuity of care for chronic conditions like diabetes and hypertension, with specialized programs including Diabetes360 for ongoing disease management. The company has recorded over 4.5 million patient interactions and is expanding its AI-enabled clinical decision-support capabilities.

Don't miss iKure Techsoft Private Limited's next move

Get an email the moment iKure Techsoft Private Limited raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for iKure Techsoft Private Limited's next move

See what Strategic adds

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

iKure Techsoft Private Limited raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.